期刊文献+

(S)-1-(2-氯乙酰基)吡咯烷-2-甲腈的合成与表征 被引量:7

Synthesis and Characterization of (S)-1-(2-Chloroacetyl)pyrrolidine-2-carbonitrile
下载PDF
导出
摘要 探讨了合成(S)-1-(2-氯乙酰基)吡咯烷-2-甲腈的新工艺路线,即以L-脯氨酸为原料,经N-氯乙酰化、羧基氨基化和酰胺脱水反应合成目标化合物。目标化合物及各中间体的结构采用1HNMR和MS进行了确定。此外,详细研究了反应条件的影响,得到了优化的反应条件。目标产物的总收率可达42.3%。该合成路线具有原料便宜易得、操作简单、条件温和等优点,具有很好的市场应用前景。 (S)- 1- (2-Chloroacetyl) pyrrolidine-2-carbonitrile was synthesized from L-proline via the processes ot N-chloroacetion, cabboxyl amination and earboxamide dehydration. The structures of the intermediates and the target compound were confirmed by 1H NMR and MS. Effect of the process conditions on reaction was investigated and the optimum parameters were obtained. The target compound was achieved in an oveval yield of 42.3%. The synthetic route has advantage of lower cost, simple operation and mild reaction condition.
出处 《精细化工中间体》 CAS 2010年第1期27-30,共4页 Fine Chemical Intermediates
关键词 合成 L-脯氨酸 (S)-1-(2-氯乙酰基)吡咯烷-2-甲腈 二肽基肽酶Ⅳ synthesis L-proline (S)- 1- (2-chloroacetyl) pyrrolidine-2-earbonitrile DPP-Ⅳ
  • 相关文献

参考文献9

  • 1Mclntosh C H, Demunth H U, Kim S J, et al. Applications of dipeptidyl peptidase Ⅳ inhibitors in diabetes mellitus[J]. Int J Boochem & Cell Biol, 2006, 38(5-6): 890-872.
  • 2Pratley R E, Salsal I A, Matf N G, et al. Inhibition of dipeptidyl peptidase-4 with vildagliptin: a potential new treatment for type 2 diabetes[J]. Br J Diabetes Vasc Dis, 2006, 6(4): 150-156.
  • 3Hughes T E, Mone M D, Russell M E, et al. NVP- DPP728 (1 -[ [ [2 -[ (5 -Cyanopy -ridiN -2 -yl) -amino]ethyl ] amino] acetyl]-2-cyano-(S)-pyrrolidine), a Slow-Binding Inhibitor of Dipeptidyl Peptidase Ⅳ [J]. Biochemistry, 1999, 38 (36): 11 597-11 603.
  • 4Augeri D J, Robl J A, Betebenner D A, et al. Discovery and preclinical profile of saxagliptin(BMS--477118): a highly potent, long-acting, orally active dipeptidyl peptidase Ⅳ inhibitor for the treatment of type 2 diabetes [J]. J Med Chem, 2005, 48 (15): 5 025-5 037.
  • 5Deng G H, Ye D J, Li Y Y, et al. Synthesis of (S)-, (R)-, and (rac)-2-amino-3,3-bis (4-fluoro-phenyl) propanoic acids and an evaluation of the DPP Ⅳ inhibitory activity of denagliptin diastereomers [J]. Terahedron, 2008, 64: 10512-10516.
  • 6Peters J U. 11 Years of cyanopyrrolidines as DPP-Ⅳ Inhibitors [J ]. Current Topics in Medicinal Chemistry, 2007, 7: 579-595.
  • 7Edwin E B, Brikman J A, Naderi G B, et al. 1-[[(3- Hydroxy -1 -adamantyl)amiN -o Jacetyl ] -2 -cyano - (S) - pyrrolidine : a potent selective, and orally bioavailable dipeptidyl peptidase inhibitor with antihyperglycemic properties[J]. J Med Chem, 2003, 46 (13): 2774-2789.
  • 8Fukushima H, Hiratate A, Takahashi M, et al. Synthesis and structure- activity relationships of potent 3- or 4- substituted -2 -cyanopyrrolidine dipeptidyl peptidase Ⅳ inhibitors [J]. Bioorganic & Medicinal Chemistry, 2004, 12: 6 053-6 061.
  • 9Santosh K S, Narendra M, Manojit P. Synthesis of (S)-1- (2 -chloroacetyl) pyrrolidine -2 -carbo -nitrile : A key intermediate for dipeptidyl peptidase Ⅳ inhibitors [J]. Beilstein Journal of Organic Chemistry, 2008, 4 (20): doi: 10.3762/bjoc.4.20.

同被引文献95

引证文献7

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部